Breaking News Instant updates and real-time market news.

PH

Parker-Hannifin

$163.81

-3.6 (-2.15%)

, ROK

Rockwell Automation

$170.00

-2.89 (-1.67%)

10:29
10/15/18
10/15
10:29
10/15/18
10:29

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Parker-Hannifin (PH) and Rockwell Automation (ROK) were downgraded to Underperform from Market Perform at Cowen. 2. Nutrisystem (NTRI) downgraded to Underperform from Neutral at DA Davidson with analyst Linda Bolton Weiser saying she is less confident in the company being able to achieve the over 30% growth in Q4 EBITDA implied by its guidance and believes that the management could cut its outlook, citing "anecdotal evidence" that "steep" price discounting of as high as 29% may be continuing for Nutrisystem's reactivation customers. 3. KLA-Tencor (KLAC) downgraded to In Line from Outperform at Evercore ISI with analyst CJ Muse saying his recent data suggest that WFE orders are tracking to fall about 10% to $45B in FY19, but the decline could be as high as 20% if memory spending does not recover from the DRAM inventory glut-driven slump. 4. Delphi Technologies (DLPH) downgraded to Equal Weight at Morgan Stanley with analyst Armintas Sinkevicius citing the "surprise" CEO transition, stating that the reasons for the change at the top are not clear. 5. Monster Beverage (MNST) downgraded to In Line from Outperform at Evercore ISI with analyst Robert Ottenstein saying he sees fitness/sports energy drinks being poised to take share from traditional energy drinks. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

PH

Parker-Hannifin

$163.81

-3.6 (-2.15%)

ROK

Rockwell Automation

$170.00

-2.89 (-1.67%)

NTRI

Nutrisystem

$34.46

-2.66 (-7.17%)

KLAC

KLA-Tencor

$91.27

-1.91 (-2.05%)

DLPH

Delphi Technologies

$23.27

-0.09 (-0.39%)

MNST

Monster Beverage

$52.46

-0.83 (-1.56%)

PH Parker-Hannifin
$163.81

-3.6 (-2.15%)

10/15/18
COWN
10/15/18
DOWNGRADE
Target $150
COWN
Underperform
Parker-Hannifin downgraded to Underperform at Cowen
As reported previously, Cowen analyst Joseph Giordano downgraded Parker-Hannifin to Underperform from Market Perform. The analyst cited heightened geopolitical risks, evidence of moderating trends, and key macro indicators with seemingly little room to the upside, and waning estimate momentum. Giordano lowered his price target to $150 from $165 on Parker-Hannifin shares.
09/27/18
WELS
09/27/18
NO CHANGE
Target $193
WELS
Market Perform
Parker-Hannifin price target raised to $193 from $185 at Wells Fargo
Wells Fargo analyst Andrew Casey raised his price for Parker-Hannifin to $193 from $185, while reiterating a Market Perform rating on the shares. The analyst believes the company appears poised to benefit from internal initiatives.
10/12/18
GDHS
10/12/18
INITIATION
Target $170
GDHS
Underperform
Parker-Hannifin initiated with an Underperform at Gordon Haskett
Gordon Haskett analyst John Inch started Parker-Hannifin with an Underperform rating and $170 price target. The analyst expects Parker to beat near term earnings estimates but feels its "cyclical profile characteristics" will drive "significantly lower" earnings in the second half of 2019 relative to consensus forecasts.
10/15/18
COWN
10/15/18
DOWNGRADE
COWN
Underperform
Parker-Hannifin downgraded to Underperform from Market Perform at Cowen
ROK Rockwell Automation
$170.00

-2.89 (-1.67%)

10/12/18
FBCO
10/12/18
INITIATION
FBCO
Outperform
EE, MI Sector initiated with Opportunistic View at Credit Suisse
Credit Suisse analyst John Walsh initiated the U.S. Electrical Equipment and Multi-Industry Sector with an Opportunistic View, telling investors in a research note that he believes at this point in the cycle stock appreciation will be driven by earnings growth and capital allocation. He is most positive on energy-related and non-residential end markets while cautious on Fossil Power markets. Specifically, Walsh initiated Allegion (ALLE), Eaton (ETN), Ingersoll-Rand (IR), Lennox (LII), 3M (MMM) and Xylem (XYL) with Outperform ratings, Acuity Brands (AYI), Emerson (EMR), Flowserve (FLS), Fortiv (FTV), GE (GE), Honeywell (HON) and Johnson Controls (JCI) with Neutral ratings and Rockwell Automation (ROK) with an Underperform rating.
10/12/18
GDHS
10/12/18
INITIATION
Target $197
GDHS
Buy
Rockwell Automation initiated with a Buy at Gordon Haskett
Gordon Haskett analyst John Inch started Rockwell Automation with a Buy rating and $197 price target.
10/15/18
COWN
10/15/18
DOWNGRADE
COWN
Underperform
Rockwell Automation downgraded to Underperform from Market Perform at Cowen
10/15/18
COWN
10/15/18
DOWNGRADE
Target $150
COWN
Underperform
Rockwell Automation downgraded to Underperform at Cowen
As reported previously, Cowen analyst Joseph Giordano downgraded Rockwell Automation to Underperform from Market Perform. The analyst cited heightened geopolitical risks, evidence of moderating trends, and key macro indicators with seemingly little room to the upside, and waning estimate momentum. Giordano lowered his price target to $150 from $175 on Rockwell Automation shares.
NTRI Nutrisystem
$34.46

-2.66 (-7.17%)

07/31/18
DADA
07/31/18
DOWNGRADE
Target $40
DADA
Neutral
Nutrisystem downgraded to Neutral at DA Davidson on valuation
As reported earlier, DA Davidson analyst Linda Bolton Weiser downgraded Nutrisystem to Neutral from Buy and lowered her price target to $40 from $45. The analyst notes that she is optimistic that the company's execution can improve in the 2019 diet season, but cautions that the stock is entering a period of seasonal weakness from late summer through Q1, having already run up 43% from its March 29th lows. Weiser believes that Nutrisystem valuation may not improve until the results of the 2019 diet season are available, also lowering her PE multiple target to 15-times from 18-times.
09/14/18
DADA
09/14/18
NO CHANGE
DADA
Neutral
Nutrisystem more likely than public peers to buy Jenny Craig, says DA Davidson
After The Wall Street Journal recently reported that private equity firm North Castle Partners is seeking a buyer of Jenny Craig, DA Davidson analyst Linda Bolton Weiser said she sees "zero probability" that Medifast (MED) would acquire it and "almost zero probability" that Weight Watchers (WTW) would buy the company. Nutrisystem (NTRI), however, has already shown an interest in adding non-cannibalizing brands to its portfolio, making it the most likely buyer of Jenny Craig among the publicly-traded weight loss companies Weiser covers, she stated. Nutrisystem, which seems to have hit a wall in growing its biggest brand, may need a bold strategic move to provide visibility on growth and expansion, added the analyst. She keeps Buy ratings on Medifast and Weight Watchers and a Neutral rating on Nutrisystem shares.
10/15/18
DADA
10/15/18
DOWNGRADE
DADA
Underperform
Nutrisystem downgraded to Underperform from Neutral at DA Davidson
10/15/18
DADA
10/15/18
DOWNGRADE
Target $28
DADA
Underperform
Nutrisystem downgraded to Underperform at DA Davidson on continued discounting
As reported earlier, DA Davidson analyst Linda Bolton Weiser downgraded Nutrisystem to Underperform from Neutral and also lowered her price target to $28 from $40. The analyst says she is less confident in the company being able to achieve the over 30% growth in Q4 EBITDA implied by its guidance and believes that the management could cut its outlook, citing "anecdotal evidence" that "steep" price discounting of as high as 29% may be continuing for Nutrisystem's reactivation customers. Weiser further notes her concern over "deteriorating Google search trends for South Beach" while also lowering her FY18 EPS view to $1.99 from $2.06.
KLAC KLA-Tencor
$91.27

-1.91 (-2.05%)

10/01/18
DBAB
10/01/18
DOWNGRADE
Target $43
DBAB
Hold
Applied Materials downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Sidney Ho downgraded Applied Materials (AMAT) to Hold and lowered his price target for the shares to $43 from $58. Semicap Equipment stocks are not expensive but lack positive catalysts, Ho tells investors in a research note. The analyst believes investor fears over that the industry has reached a cyclical peak will remain as long as the memory market stays weak. Further, he sees risk is for additional capex push-outs, especially in the first half of 2019. With this setup, the analyst prefers companies with a defensive business model like Entegris (ENTG) or stocks that look mispriced like MKS Instruments (MKSI) over broad-based names Applied Materials, Lam Research (LRCX) and KLA-Tencor (KLAC).
10/10/18
GSCO
10/10/18
NO CHANGE
GSCO
Goldman Sachs cuts estimates for Semi Capital Equipment makers after checks
Goldman Sachs analyst Toshiya Hari lowered his estimates for Semiconductor Capital Equipment makers Applied Materials (AMAT), Lam Research (LRCX) and KLA-Tencor (KLAC) as his recent industry checks lead him to believe that the market could be underestimating the magnitude of a cyclical downturn driven by weakness in memory. Hari lowered his EPS estimates for Applied, Lam and KLA-Tencor by an average of 11% and 4%, respectively, for calendar 2019 and 2020. The analyst also cut his price target Lam to $156 from $180 and lowered his target for Applied to $40 from $47 and keeps Neutral ratings on both.
10/15/18
EVER
10/15/18
DOWNGRADE
EVER
In Line
KLA-Tencor downgraded to In Line from Outperform at Evercore ISI
10/15/18
EVER
10/15/18
DOWNGRADE
Target $100
EVER
In Line
KLA-Tencor downgraded to In Line at Evercore ISI on recent shipment cuts
As reported earlier, Evercore ISI analyst CJ Muse dowgraded KLA-Tencor to In Line from Outperform and also lowered his price target to $100 from $140. The analyst says his recent data suggest that WFE orders are tracking to fall about 10% to $45B in FY19, but the decline could be as high as 20% if memory spending does not recover from the DRAM inventory glut-driven slump. Muse also notes that the recent shipment cut data indicate that KLA-Tencor is poised for the "worst peak to tough decline" of about 50%, which could lead to "incremental disappointment" in the current earnings season.
DLPH Delphi Technologies
$23.27

-0.09 (-0.39%)

10/15/18
10/15/18
DOWNGRADE
Target $30

Equal Weight
Morgan Stanley downgrades Delphi to Equal Weight on lack of visibility
As previously reported, Morgan Stanley analyst Armintas Sinkevicius downgraded Delphi Technologies to Equal Weight from Overweight following the "surprise" CEO transition, stating that the reasons for the change at the top are not clear. He finds it hard to recommend a stock after a significant negative revision to guidance when the company does not have a permanent CEO, Sinkevicius tells investors. After management lowered its guidance for adjusted operating income by over 20% for the second half of 2018, Sinkevicius said he does not see significant improvement into 2019 and cut his own estimates for 2019 adjusted operating income by about 25%. He lowered his price target on Delphi shares to $30 from $52.
10/15/18
MSCO
10/15/18
DOWNGRADE
MSCO
Equal Weight
Delphi Technologies downgraded to Equal Weight at Morgan Stanley
10/11/18
10/11/18
DOWNGRADE
Target $30

Neutral
Goldman Sachs sees less clear path for Delphi, downgrades to Neutral
As previously reported, Goldman Sachs analyst David Tamberrino downgraded Delphi Technologies to Neutral from Buy and lowered his price target for the shares to $30 from $53. Delphi's revenue growth and margin profile have seen downward revisions since the company's spinoff last year and pairing this with the departure of CEO Liam Butterworth leaves Tamberrino with longer-term concerns about the company's previously laid out trajectory, he tells investors. The analyst, who believes margin pressure will likely persist as revenues shift from higher profit light duty diesel, cut his 2018-2020 EPS estimates by an average 17%.
10/11/18
GSCO
10/11/18
DOWNGRADE
Target $30
GSCO
Neutral
Delphi Technologies downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst David Tamberrino downgraded Delphi Technologies to Neutral and lowered his price target for the shares to $30 from $53. The company's path forward is less clear following the departure of CEO Liam Butterworth, Tamberrino tells investors in a research note.
MNST Monster Beverage
$52.46

-0.83 (-1.56%)

09/18/18
STFL
09/18/18
NO CHANGE
Target $66
STFL
Buy
Monster Beverage likely to hike prices regardless of Red Bull, says Stifel
Stifel analyst Mark Astrachan said he still anticipates Monster Beverage will increase prices on its U.S. legacy business, which represents about two-thirds of sales, by about 4% in the fourth quarter of 2018 and raise prices on its brands acquired from Coca-Cola (KO) in the first quarter of 2019 despite industry talks that indicate Red Bull does not currently plan to follow Monster's lead. While noting that he does not view Red Bull's reported lack of current pricing intent as definitive, Astrachan said that should it not follow that he anticipates no material impact to Monster's volume or share trends based on his analysis of the last price increase by both companies in 2015. He maintains a Buy rating and $66 price target on Monster shares.
10/15/18
EVER
10/15/18
DOWNGRADE
EVER
In Line
Monster Beverage downgraded to In Line from Outperform at Evercore ISI
10/15/18
10/15/18
DOWNGRADE

In Line
Monster Beverage downgraded to In Line on potential disruption at Evercore ISI
As previously reported, Evercore ISI analyst Robert Ottenstein downgraded Monster Beverage to In Line from Outperform as he sees fitness/sports energy drinks being poised to take share from traditional energy drinks. He believes the fact that Monster is working on products that do not carry the Monster trademark suggests the company's concern. If this change is not just evolutionary but "truly disruptive, "incumbents such as Monster may be at risk, Ottenstein tells investors.
09/14/18
GUGG
09/14/18
INITIATION
Target $72
GUGG
Buy
Monster Beverage initiated with a Buy on strong fundamentals at Guggenheim
Guggenheim analyst Laurent Grandet initiated Monster Beverage with a Buy and $72 price target saying it has among the strongest fundamentals in the industry driven by leading organic sales growth, a healthy US energy drink category, continued shares gains, innovation in "energy-adjacent" segments, and international expansion supported by the Coca-Cola global distribution system.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/18/19
10/18
14:17
10/18/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/18/19
10/18
14:16
10/18/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$82.71

-1.42 (-1.69%)

14:15
10/18/19
10/18
14:15
10/18/19
14:15
Options
Diamondback Energy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

QQQ

Invesco QQQ Trust

$192.00

-1.56 (-0.81%)

, SPY

SPDR S&P 500 ETF Trust

$298.50

-0.74 (-0.25%)

14:13
10/18/19
10/18
14:13
10/18/19
14:13
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week creations…

QQQ

Invesco QQQ Trust

$192.00

-1.56 (-0.81%)

SPY

SPDR S&P 500 ETF Trust

$298.50

-0.74 (-0.25%)

IWM

iShares Trust Russell 2000 Index Fund

$152.78

-0.56 (-0.37%)

XLU

Utilities SPDR

$63.76

0.16 (0.25%)

IVV

iShares Core S&P 500

$300.17

-0.76 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XEC

Cimarex Energy

$42.31

-0.36 (-0.84%)

14:05
10/18/19
10/18
14:05
10/18/19
14:05
Options
Cimarex Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

SPXC

SPX Corporation

$40.48

0.265 (0.66%)

13:58
10/18/19
10/18
13:58
10/18/19
13:58
Initiation
SPX Corporation initiated  »

SPX Corporation initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

WE

We Company

$0.00

(0.00%)

, JPM

JPMorgan

$120.80

0.41 (0.34%)

13:58
10/18/19
10/18
13:58
10/18/19
13:58
Periodicals
SoftBank, JPMorgan submit competing rescue packages for WeWork, FT says »

SoftBank (SFTBF) and…

WE

We Company

$0.00

(0.00%)

JPM

JPMorgan

$120.80

0.41 (0.34%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 27

    Oct

  • 04

    Nov

  • 21

    Nov

  • 14

    Jan

13:55
10/18/19
10/18
13:55
10/18/19
13:55
General news
Action Economics Survey results: »

Action Economics Survey…

JNJ

Johnson & Johnson

$129.11

-7.09 (-5.21%)

13:48
10/18/19
10/18
13:48
10/18/19
13:48
Recommendations
Johnson & Johnson analyst commentary  »

Credit Suisse says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 07

    Dec

DIS

Disney

$131.17

-1.2 (-0.91%)

, SNE

Sony

$58.86

-1.195 (-1.99%)

13:47
10/18/19
10/18
13:47
10/18/19
13:47
On The Fly
Box Office Battle: 'Maleficent,' 'Zombieland' sequels hit theaters »

Welcome to "Box Office…

DIS

Disney

$131.17

-1.2 (-0.91%)

SNE

Sony

$58.86

-1.195 (-1.99%)

T

AT&T

$38.09

0.27 (0.71%)

VIA

Viacom

$25.00

-0.6 (-2.34%)

VIAB

Viacom

$22.24

-0.37 (-1.64%)

CMCSA

Comcast

$45.49

-0.45 (-0.98%)

CMCSK

Comcast

$0.00

(0.00%)

LGF.A

Lionsgate

$8.50

-0.1 (-1.16%)

LGF.B

Lionsgate

$8.00

-0.07 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 14

    Nov

  • 14

    Nov

  • 18

    Nov

  • 19

    Nov

MAS

Masco

$43.82

0.18 (0.41%)

13:45
10/18/19
10/18
13:45
10/18/19
13:45
Options
Masco call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

IGT

International Game

$13.15

-0.25 (-1.87%)

13:25
10/18/19
10/18
13:25
10/18/19
13:25
Options
International Game call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
10/18/19
10/18
13:25
10/18/19
13:25
General news
Wall Street is taking a hit on a couple of news items »

Wall Street is taking a…

13:25
10/18/19
10/18
13:25
10/18/19
13:25
Conference/Events
JPMorgan autos/auto parts analyst to hold an analyst/industry conference call »

Autos & Auto Parts…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
10/18/19
10/18
13:17
10/18/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
10/18/19
10/18
13:16
10/18/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GGAL

Grupo Financiero

$12.45

-0.05 (-0.40%)

13:15
10/18/19
10/18
13:15
10/18/19
13:15
Options
Grupo Financiero put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWBO

Northwest Biotherapeutics

$0.00

(0.00%)

13:12
10/18/19
10/18
13:12
10/18/19
13:12
Syndicate
Breaking Syndicate news story on Northwest Biotherapeutics »

Northwest Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BA

Boeing

$355.77

-13.36 (-3.62%)

13:12
10/18/19
10/18
13:12
10/18/19
13:12
Periodicals
Boeing pilot said he 'lied' to FAA in texts to colleague, NY Times reports »

Mark Forkner, a Boeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

MAT

Mattel

$11.18

0.07 (0.63%)

13:06
10/18/19
10/18
13:06
10/18/19
13:06
Recommendations
Mattel analyst commentary  »

Jefferies sees increased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

13:05
10/18/19
10/18
13:05
10/18/19
13:05
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 10/18…

FEYE

FireEye

$15.06

-0.06 (-0.40%)

13:05
10/18/19
10/18
13:05
10/18/19
13:05
Options
FireEye call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

BHGE

Baker Hughes

$0.00

(0.00%)

13:03
10/18/19
10/18
13:03
10/18/19
13:03
Hot Stocks
Baker Hughes reports U.S. rig count down 5 to 851 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

MAT

Mattel

$11.26

0.15 (1.35%)

12:59
10/18/19
10/18
12:59
10/18/19
12:59
Periodicals
Study finds Fisher-Price Rock 'n Play 'dangerous and deadly,' CBS News says »

A study has found that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

NKE

Nike

$95.67

0.13 (0.14%)

12:55
10/18/19
10/18
12:55
10/18/19
12:55
Options
Nike put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.